Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Kraig Biocraft Laboratories (KBLB) EBT Margin (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed EBT Margin for 6 consecutive years, with 1278.64% as the latest value for Q4 2022.

  • Quarterly EBT Margin rose 291182614.0% to 1278.64% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 630.74% through Dec 2022, down 189435.0% year-over-year, with the annual reading at 978.55% for FY2025, 33676.0% up from the prior year.
  • EBT Margin hit 1278.64% in Q4 2022 for Kraig Biocraft Laboratories, up from 1084.13% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1691.55% in Q3 2021 to a low of 2910547.5% in Q4 2021.
  • Historically, EBT Margin has averaged 290530.43% across 3 years, with a median of 497.2% in 2022.
  • Biggest YoY gain for EBT Margin was 291182614bps in 2022; the steepest drop was -60742bps in 2022.
  • Year by year, EBT Margin stood at 147.04% in 2018, then crashed by -1979268bps to 2910547.5% in 2021, then skyrocketed by 100bps to 1278.64% in 2022.
  • Business Quant data shows EBT Margin for KBLB at 1278.64% in Q4 2022, 1084.13% in Q3 2022, and 347.85% in Q2 2022.